MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A 16-week open-label study of the effects of treatment with pimavanserin on activities of daily living in subjects with Parkinson’s disease psychosis (PDP)

    V. Evidente, D. Dekarske, B. Coate, V. Abler (Scottsdale, USA)

    Objective: To examine the effects of pimavanserin on activities of daily living during treatment for Parkinson’s Disease psychosis. Background: Accurate assessment of disability associated with…
  • 2023 International Congress

    Dopaminergic neuronal cell therapy for Parkinson’s Disease: results from a phase 1 study of Bemdaneprocel

    C. Henchcliffe, H. Sarva, A. Lozano, A. Fasano, S. Kalia, C. Brennan, K. Yu, M. Yountz, A. Enayetallah, A. Lampron, V. Tabar (Orange, USA)

    Objective: This first-in-human Phase 1 study aims to assess the safety, tolerability, clinical efficacy, and functional imaging measures of bemdaneprocel in subjects with PD. Background:…
  • 2023 International Congress

    Predicting clinical response after Gamma Knife thalamotomy in essential tremor

    R. Barriol, G. Carey, G. Touzet, L. Defebvre, N. Carrière (Lille, France)

    Objective: To determine clinical, surgical and radiological factors associated with tremor reduction after Gamma Knife thalamotomy (GKT) for essential tremor (ET). Background: GKT is a…
  • 2023 International Congress

    Deep brain stimulation for the management of movement disorders in Rett syndrome

    M. Hull, D. Curry, M. Parnes (Houston, USA)

    Objective: We present two patients with Rett syndrome who underwent deep brain stimulation (DBS) for management of action tremor and rigidity. Video segments of the…
  • 2023 International Congress

    Brain-behavior quantification and synchronization to drive closed-loop deep brain stimulation

    A. Gunduz, D. Johnson, M. Okun, K. Foote (Gainesville, USA)

    Objective: Closed-loop DBS systems require a neural biomarker to responsively turn on stimulation, which in turn requires neurophysiological quantification synchronized to behavior or symptoms. Our…
  • 2023 International Congress

    Determinants of care partner burden in atypical parkinsonian syndromes

    M. Ivancic, J. Shurer, M. Schmidt, V. Nesspor, M. Li, Y. Lin, R. Xu, G. Schumock, M. Sklerov, A. Pantelyat (Chapel Hill, USA)

    Objective: To understand the determinants of burden among people caring for individuals diagnosed with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), or multiple system atrophy…
  • 2023 International Congress

    Sleep hygiene practice in patients with Parkinson’s disease

    JY. Yun, CY. Lee, D. Kim, JH. Kim (Seoul, Republic of Korea)

    Objective: We examined the prevalence of diverse sleep hygiene behavior and their associations with insomnia severity in PD patients.We examined the prevalence of diverse sleep…
  • 2023 International Congress

    Radiological markers of CSF α-synuclein aggregation in Parkinson’s disease patients

    A. Droby, A. Yoffe-Vasiliev, K. Fraser, O. Mabrouk, B. Cohen, N. Omer, A. Bar Shira, M. Gana-Weisz, O. Goldstein, R. Alcalay, A. Orr-Urtreger, J. Shirvan, J. Cedarbaum, N. Giladi, A. Mirelman, A. Thaler (Tel-Aviv, Israel)

    Objective: To investigate the association between cerebrospinal (CSF) αS aggregates, MRI, and dopamine transporter spectral tomography (DaTscanTM) imaging metrics. Background: Synuclein amplification assays (SAA) enables…
  • 2023 International Congress

    Effect of intensive Game-based neurorehabilitation (GBNR) on gait, balance and quality of life (QOL) in Parkinson’s patients: A prospective randomized control study

    R. Savaj, P. Vengurlekar, C. Sankhla, S. Patel (Mumbai, India)

    Objective: To assess changes in the gait, balance and QOL in PD patients subjected to intensive GBNR in comparison with conventional Neurorehabilitation (NR) therapy using…
  • 2023 International Congress

    Concealment of Parkinson’s Disease: Prevalence and Impact on Health and Quality of Life

    G. Yogev-Seligmann, B. Naamneh Abuelhija, M. Giveon, M. Meir Kestenbaum, M. Kafri (Haifa, Israel)

    Objective: (1) To explore the proportion and personal characteristics of patients who do not disclose their diagnosis of Parkinson's disease (PD) to their family, and…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley